A purity percentage becomes meaningful only when its measurement is explained. In peptide work, a high-performance liquid chromatography result may describe the relative areas of detected peaks under a particular method. It does not automatically report the absolute amount of the desired molecule in the container or establish freedom from microbial contamination.

Separate the analytical questions

Identity asks whether the intended chemical species is present. Assay asks how much is present. Related-substance testing examines specified impurities. Water, residual solvents, counterions and microbial attributes may require different methods. A strong result in one category cannot fill in missing results in another.

FDA's analytical validation guidance describes the need to establish that a procedure performs appropriately for its intended purpose. A method's selectivity, accuracy, precision and relevant range affect how a reported number should be interpreted. A number without method context is therefore an incomplete description of evidence. FDA Q2 R2 analytical procedure validation guidance

Compare like with like

Two suppliers can both report 99 percent while using different methods, acceptance rules or sample preparation. That does not necessarily mean either result is fraudulent; it means the numbers may answer different questions. Ask whether the report identifies the tested batch, whether the laboratory measured an actual submitted sample and whether the report can be authenticated.

The Q7 pharmaceutical quality framework treats certificates, specifications, traceability and supplier qualification as connected controls. It does not make a purity threshold equivalent to clinical suitability. FDA Q7 guidance for active pharmaceutical ingredient quality

For a research team, the right specification starts with the experiment. An impurity that is irrelevant to one analytical exercise may interfere with another assay. For human treatment, quality requirements extend far beyond a retail certificate and must be addressed through the appropriate regulated pathway.

AXON should explain purity claims with their method and limitations, not advertise a universal percentage as proof of safety. No company was ranked or verified for this article, and no AXON batch has been assessed by the evidence presented here.